Stem Cell News

BioInformant's coverage of stem cell news includes iPS cells, mesenchymal stem cells, hematopoietic stem cells, neural stem cells and more.

As the first and only market research firm to specialize in stem cell news, BioInformant research has been cited by the Wall Street Journal, Xconomy, AABB, and Vogue Magazine.

Serving Fortune 500 leaders that include GE Healthcare, Pfizer, and Goldman Sachs, BioInformant is your global leader in stem cell industry news.

B-MoGen Biotechnologies, a Bio-Techne Company, Announces Opening of 2 Class 7 Clean Suites for Cellular Therapy Manufacturing

July 9, 2020 By Cade Hildreth, Founder & President Leave a Comment

Contract Development & Manufacturing (CDMO):
B-MoGen’s ISO 7 cleanrooms now open for business

B-MoGen Biotechnologies, a unit of Bio-Techne, is proud to announce new cGMP cellular therapy manufacturing capacity for Phase I and Phase II clinical trials.

[Read more…]

Luminary Therapeutics and Case Western Reserve University Enter Formal Collaboration for Development of BAFF CAR

July 7, 2020 By Cade Hildreth, Founder & President Leave a Comment

Luminary Tx and CWRU enter formal collaboration for clinical development of novel BAFF CAR to treat Mantle Cell Lymphoma and Sjogren’s Syndrome

MINNEAPOLIS, MN, USA, July 7, 2020– Luminary Therapeutics (Luminary Tx) and Case Western Reserve University have entered into a formal collaboration agreement that includes an option for Luminary to exclusively license a novel BAFF target for use in CAR-T (chimeric antigen receptor T cells) constructs. [Read more…]

AASCP to Host 1st Virtual Board Certification Ceremony for Stem Cell Physicians

July 6, 2020 By Cade Hildreth, Founder & President Leave a Comment

The American Academy of Stem Cell Physicians (AAOSCP) will create history on August 2, 2020, by hosting the first virtual Board Certification for Stem Cell Physicians.

On August 2-4, 2019, the American Academy of Stem Cell Physicians hosted a Scientific Congress at the Hyatt Regency in Miami, Florida. The highly anticipated event featured three days of educational and events with leading physicians and pioneers from across the fields of stem cell, live cell and regenerative medicine.

During this event, the AASCP Scientific Congress offered the first Board Certifications to eligible stem cell physicians. A challenging three-hour written examination for Board Certification was conducted, creating a pathway for Diplomat and Fellowship Certification in Regenerative Medicine (RM).

This year, the AASCP’s Congress will be delivered over August 1-2, 2020, and will include the first Virtual Board Certification for Stem Cell Physicians. [Read more…]

Aspire Health Science LLC, Announces Release of ACP-01 Midpoint Analysis to Hemostemix Inc.

July 6, 2020 By Cade Hildreth, Founder & President Leave a Comment

ORLANDO, Fla., July 6, 2020 – Aspire Health Science, LLC (the “Company” or “Aspire”), is an FDA registered cGMP manufacturing facility specializing in the research, development, and manufacturing of cell-based therapies. [Read more…]

Off-the-shelf NK cells in hematologic malignancies and oncology

July 3, 2020 By Cade Hildreth, Founder & President 1 Comment

Key Points:

Natural killer (NK) cells represent innate immune cells with potent antitumor activity.
Glycostem Therapeutics has established an innovative production process that yields high numbers of allogeneic NK cells with potent activity towards both hematologic and solid malignancies which can be used “off-the-shelf”.
In a first-in-human phase I study in elderly patients with acute myeloid leukemia, these NK cells were well tolerated, had a favorable toxicity profile and were associated with promising efficacy.
The possibility to genetically engineer the NK cells with chimeric antigen receptors or T cell receptors offers additional opportunities in immuno-oncology.